■ Incidence of Chronic Kidney Disease According to Steatotic Liver Disease and Its Subclassifications: A Longitudinal Cohort Study, Gut Liver, 2025

■ Cardiometabolic risk factors and coronary atherosclerosis progression in patients with metabolic dysfunction-associated steatotic liver disease: the influential role of quantity over type, J Gastroenterol Hepatol, 2025

■ Assessing the Validity of the AASLD Surgical Treatment Algorithm in Patients with Early-Stage Hepatocellular Carcinoma, Gut Liver, 2025

■ New nomenclature and subclassification of steatotic liver disease and loss of skeletal muscle mass: A longitudinal cohort study, Hepatol Res, 2024

■ Hepatocellular carcinoma outcomes and potential implications for surveillance in elderly patients, Sci Rep, 2024

■ Massive Transfusion Protocol and Outcome of Patients with Acute Variceal Bleeding, J Clin Med, 2024

■ Prevalence and Predictors of Multidrug Resistant Bacteremia in Liver Cirrhosis, Korean J Intern Med, 2024

■ Steatotic liver disease and its newly proposed sub-classifications correlate with progression of the coronary artery calcium score, PLoS One, 2024

■ Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Sub-Classification, Liver Cancer, 2024

■ Clinicopathologic and Endosonographic Characteristics of Colon Subepithelial Tumors Discovered Incidentally, Diagnostics, 2024

■ Risk factors and management of iatrogenic colorectal perforation in diagnostic colonoscopy: a single-center cohort study, Scand J Gastroenterol, 2024

■ Supplementation with Angelica keiskei inhibits expression of inflammatory mediators in the gastric mucosa of Helicobacter pylori-infected mice, Nutr Res, 2016

■ Glutamine deprivation induces interleukin-8 expression in ataxia telangiectasia fibroblasts, Inflamm Res, 2014